An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
Authors
Keywords
-
Journal
Neurotherapeutics
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-15
DOI
10.1007/s13311-022-01183-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using bumetanide to treat autism appears promising but further clinical trials are needed to confirm this approach
- (2021) Yehezkel Ben‐Ari et al. ACTA PAEDIATRICA
- Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
- (2021) Hana Štorkánová et al. Scientific Reports
- Targeting the RHOA pathway improves learning and memory in adult Kctd13 and 16p11.2 deletion mouse models
- (2021) Sandra Martin Lorenzo et al. Molecular Autism
- Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
- (2021) Felipe Patricio et al. Frontiers in Pharmacology
- Intranasal oxytocin in the treatment of autism spectrum disorders: A multilevel meta-analysis
- (2021) Yi Huang et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cannabinoid treatment for autism: a proof-of-concept randomized trial
- (2021) Adi Aran et al. Molecular Autism
- Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial
- (2021) Elizabeth M. Berry-Kravis et al. NATURE MEDICINE
- Probiotic and Oxytocin Combination Therapy in Patients with Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial
- (2021) Xue-Jun Kong et al. Nutrients
- Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database
- (2021) Aliya G. Feroe et al. JAMA Pediatrics
- Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder
- (2021) Linmarie Sikich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018
- (2021) Matthew J. Maenner et al. MMWR Surveillance Summaries
- Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder
- (2020) Ashura Williams Buckley et al. NEUROLOGY
- The Sigma-1 Receptor at the Crossroad of Proteostasis, Neurodegeneration, and Autophagy
- (2020) Maximilian G. Christ et al. TRENDS IN NEUROSCIENCES
- Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up
- (2020) Sylvie Bernaerts et al. Molecular Autism
- Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems
- (2020) Mohammad M. Kamal et al. ARCHIVES OF PHARMACAL RESEARCH
- Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome
- (2020) Angela John Thurman et al. Journal of Neurodevelopmental Disorders
- Effects of sulforaphane on brain mitochondria: mechanistic view and future directions
- (2020) Fernanda Rafaela Jardim et al. Journal of Zhejiang University-SCIENCE B
- A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome
- (2020) Elizabeth Berry-Kravis et al. PEDIATRIC NEUROLOGY
- Rationale, design, and methods of the autism centers of excellence (ACE) network study of oxytocin in autism to improve reciprocal social behaviors (SOARS-B)
- (2020) Marina Spanos et al. Contemporary Clinical Trials
- Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase Two, Superiority Trial
- (2020) Jan J. Sprengers et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments
- (2020) Richard E. Frye Seminars in Pediatric Neurology
- IGF-1 treatment causes unique transcriptional response in neurons from individuals with idiopathic autism
- (2020) Sara B. Linker et al. Molecular Autism
- Practitioner Review: Pharmacological treatment of attention‐deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta‐analysis
- (2020) Rebecca Rodrigues et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Bumetanide for autism: Open‐label trial in six children
- (2020) Elisabeth Fernell et al. ACTA PAEDIATRICA
- Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome
- (2019) Daniel G. Glaze et al. NEUROLOGY
- Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin‐two cases
- (2019) Dragana Protic et al. Molecular Genetics & Genomic Medicine
- Systematic Review of Sleep Disturbances and Circadian Sleep Desynchronization in Autism Spectrum Disorder: Toward an Integrative Model of a Self-Reinforcing Loop
- (2019) Claudia Carmassi et al. Frontiers in Psychiatry
- A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome
- (2019) Helen Heussler et al. Journal of Neurodevelopmental Disorders
- Metformin treatment in young children with fragile X syndrome
- (2019) Hazel Maridith B. Biag et al. Molecular Genetics & Genomic Medicine
- Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders
- (2019) Md. Sahab Uddin et al. SCIENCE OF THE TOTAL ENVIRONMENT
- A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder
- (2019) Laura A. Potter et al. Frontiers in Psychiatry
- ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome
- (2019) Walter E. Kaufmann et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial
- (2018) Hidenori Yamasue et al. MOLECULAR PSYCHIATRY
- Inferential language use by school-aged boys with fragile X syndrome: Effects of a parent-implemented spoken language intervention
- (2018) Sarah Nelson et al. JOURNAL OF COMMUNICATION DISORDERS
- Bumetanide for autism: more eye contact, less amygdala activation
- (2018) Nouchine Hadjikhani et al. Scientific Reports
- Bumetanide for Autism Spectrum Disorder in Children: A Review of Randomized Controlled Trials
- (2018) B. Jordan James et al. ANNALS OF PHARMACOTHERAPY
- Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders
- (2018) Ilse Gantois et al. Annual Review of Medicine
- A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder
- (2018) Hajar Mazahery et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Arbaclofen in fragile X syndrome: results of phase 3 trials
- (2017) Elizabeth Berry-Kravis et al. Journal of Neurodevelopmental Disorders
- Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder
- (2017) Paul Gringras et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- R-Baclofen Reverses Cognitive Deficits and Improves Social Interactions in Two Lines of 16p11.2 Deletion Mice
- (2017) Laura J Stoppel et al. NEUROPSYCHOPHARMACOLOGY
- The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors
- (2017) T. Bakas et al. PHARMACOLOGICAL RESEARCH
- Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism
- (2017) Karen J. Parker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
- (2017) E Lemonnier et al. Translational Psychiatry
- Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D)
- (2017) Mark E. Gurney et al. Scientific Reports
- NEW EXPLORATORY ALZHEIMER’S DRUG ANAVEX 2-73: DOSE DEPENDENT CLINICAL COGNITIVE IMPROVEMENT OBSERVED IN MINI MENTAL STATE EXAMINATION (MMSE) AND OTHER COGNITIVE MARKERS IN A PHASE 2A STUDY IN MILD-TO-MODERATE ALZHEIMER’S PATIENTS
- (2016) Stephen Macfarlane et al. Alzheimers & Dementia
- Sulforaphane Treatment of Young Men with Autism Spectrum Disorder
- (2016) Kanwaljit Singh et al. CNS & Neurological Disorders-Drug Targets
- A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome
- (2016) Laura Greiss Hess et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- Effects of Methylphenidate on Sleep Functioning in Children with Attention-Deficit/Hyperactivity Disorder
- (2016) Stephen P. Becker et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- Insulin signaling misregulation underlies circadian and cognitive deficits in a Drosophila fragile X model
- (2016) R E Monyak et al. MOLECULAR PSYCHIATRY
- Intranasal Oxytocin Enhances Connectivity in the Neural Circuitry Supporting Social Motivation and Social Perception in Children with Autism
- (2016) Ilanit Gordon et al. Scientific Reports
- Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome
- (2015) Mei Qin et al. BEHAVIOURAL BRAIN RESEARCH
- A Pilot Study on the Combination of Applied Behavior Analysis and Bumetanide Treatment for Children with Autism
- (2015) Lin Du et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial
- (2015) C J Yatawara et al. MOLECULAR PSYCHIATRY
- NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome
- (2015) Robert M. J. Deacon et al. NEUROMOLECULAR MEDICINE
- GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism
- (2015) J L Silverman et al. NEUROPSYCHOPHARMACOLOGY
- Early Intervention for Children With Autism Spectrum Disorder Under 3 Years of Age: Recommendations for Practice and Research
- (2015) L. Zwaigenbaum et al. PEDIATRICS
- Update on the implication of potassium channels in autism: K+ channelautism spectrum disorder
- (2015) Luca Guglielmi Frontiers in Cellular Neuroscience
- Cytotoxic and Antitumor Activity of Sulforaphane: The Role of Reactive Oxygen Species
- (2015) Piero Sestili et al. Biomed Research International
- Intranasal oxytocin in the treatment of autism spectrum disorders: A review of literature and early safety and efficacy data in youth
- (2014) Evdokia Anagnostou et al. BRAIN RESEARCH
- The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial
- (2014) Adam J. Guastella et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Sulforaphane treatment of autism spectrum disorder (ASD)
- (2014) K. Singh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resequencing and association analysis ofOXTRwith autism spectrum disorder in a Japanese population
- (2014) Jun Egawa et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Alpha-2 Agonists for Attention-Deficit/Hyperactivity Disorder in Youth: A Systematic Review and Meta-Analysis of Monotherapy and Add-On Trials to Stimulant Therapy
- (2013) Tomoya Hirota et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients
- (2013) Aleksandr Shcheglovitov et al. NATURE
- Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome
- (2013) Emily K. Osterweil et al. NEURON
- Comorbidity Clusters in Autism Spectrum Disorders: An Electronic Health Record Time-Series Analysis
- (2013) Finale Doshi-Velez et al. PEDIATRICS
- Psychotropic Medication Use and Polypharmacy in Children With Autism Spectrum Disorders
- (2013) D. Spencer et al. PEDIATRICS
- Oxytocin enhances brain function in children with autism
- (2013) I. Gordon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Decreased tryptophan metabolism in patients with autism spectrum disorders
- (2013) Luigi Boccuto et al. Molecular Autism
- Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay
- (2013) Ozlem Bozdagi et al. Molecular Autism
- A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism
- (2012) Antonio Y. Hardan et al. BIOLOGICAL PSYCHIATRY
- Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells
- (2012) NILUFAR ESFAHANIAN et al. Molecular Medicine Reports
- Brain-derived neurotrophic factor increases the motility of a particular N-methyl-d-aspartate /GABA-responsive subset of neural progenitor cells
- (2012) L.C. Jansson et al. NEUROSCIENCE
- Use of Psychotropic Medication in Children and Adolescents With Autism Spectrum Disorders
- (2012) Daniel L. Coury et al. PEDIATRICS
- Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen
- (2012) C. Henderson et al. Science Translational Medicine
- Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial
- (2012) E. M. Berry-Kravis et al. Science Translational Medicine
- Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial
- (2012) Evdokia Anagnostou et al. Molecular Autism
- A randomised controlled trial of bumetanide in the treatment of autism in children
- (2012) E Lemonnier et al. Translational Psychiatry
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Prosocial effects of oxytocin and clinical evidence for its therapeutic potential
- (2011) Nadine Striepens et al. FRONTIERS IN NEUROENDOCRINOLOGY
- The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects
- (2010) Eric Lemonnier et al. ACTA PAEDIATRICA
- Frequency of symptoms of attention deficit and hyperactivity disorder in autistic children
- (2010) Milena Pereira Pondé et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Autism Spectrum Disorder and Co-occurring Developmental, Psychiatric, and Medical Conditions Among Children in Multiple Populations of the United States
- (2010) Susan E. Levy et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- The role of fragile X mental retardation protein in major mental disorders
- (2010) S. Hossein Fatemi et al. NEUROPHARMACOLOGY
- Fragile X mental retardation protein levels are decreased in major psychiatric disorders
- (2010) S. Hossein Fatemi et al. SCHIZOPHRENIA RESEARCH
- Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum Disorders
- (2009) Adam J. Guastella et al. BIOLOGICAL PSYCHIATRY
- Attention Deficit/Hyperactivity Disorder in Children and Adolescents With Autism Spectrum Disorder
- (2009) Judith Sinzig et al. Journal of Attention Disorders
- Psychiatric Disorders in Children With Autism Spectrum Disorders: Prevalence, Comorbidity, and Associated Factors in a Population-Derived Sample
- (2009) Emily Simonoff et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Randomized, Controlled Trial of an Intervention for Toddlers With Autism: The Early Start Denver Model
- (2009) G. Dawson et al. PEDIATRICS
- Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
- (2009) R. Owen et al. PEDIATRICS
- Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
- (2009) Daniela Tropea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum Disorders
- (2008) D. S. Mandell et al. PEDIATRICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started